Protective effects of curcumin against spinal cord injury
Open Access
Abstract
Background: In parallel with population aging, the prevalence of neurological and neurodegenerative diseases has been dramatically increasing over the past few decades. Neurodegenerative diseases reduce the quality of life of patients and impose a high cost on the health system. These slowly progressive diseases can cause functional, perceptual, and behavioral deficits in patients. Therefore, neurodegenerative impairments have always been an interesting subject for scientists and clinicians. One of these diseases is spinal cord injury (SCI). SCI can lead to irreversible damage and is classified into two main subtypes: traumatic and non‐traumatic, each with very different pathophysiological features.Aims: This review aims to gather relevant information about the beneficial effects of curcumin (Cur), with specific emphasis on its anti‐inflammatory properties towards spinal cord injury (SCI) patients.Materials & Methods: The review collates data from extensive in‐vitro, in‐vivo, and clinical trials documenting the effects of CUR on SCI. It examines the modulation of pathophysiological pathways and regulation of the inflammatory cascades after CUR administration.Results: Various pathophysiological processes involving the nuclear factor erythroid 2‐related factor 2 (Nrf2), nuclear factor kappa B (NF‐kB), and transforming growth factor beta (TGF‐β) signaling pathways have been suggested to exacerbate damages resulting from SCI. CUR administration showed to modulate these signaling pathways which lead to attenuation of SCI complications.Discussion: Anti‐inflammatory compounds, particularly CUR, can modulate these pathophysiological pathways and regulate the inflammatory cascades. CUR, a well‐known natural product with significant anti‐inflammatory effects, has been extensively documented in experimental and clinical trials.Conclusion: Curcumin's potential to alter key steps in the Nrf2, NF‐kB, and TGF‐β signaling pathways suggests that it may play a role in attenuating SCI complications.Keywords
This publication has 97 references indexed in Scilit:
- Cancer chemopreventive activity of the prenylated coumarin, umbelliprenin, in vivoEuropean Journal Of Cancer Prevention, 2009
- Secondary pathology following contusion, dislocation, and distraction spinal cord injuriesExperimental Neurology, 2008
- Nuclear factor‐κB decoy amelioration of spinal cord injury‐induced inflammation and behavior outcomesJournal of Neuroscience Research, 2007
- Nonsteroidal Anti-Inflammatory Drugs Promote Axon Regeneration via RhoA InhibitionThe Journal of Neuroscience, 2007
- Characterization of the Early Neuroinflammation After Spinal Cord Injury in MiceJournal of Neuropathology & Experimental Neurology, 2007
- Therapeutic interventions after spinal cord injuryNature Reviews Neuroscience, 2006
- TLR Signaling2006
- Intrathecal Ketorolac Pretreatment Reduced Spinal Cord Ischemic Injury in RatsAnesthesia & Analgesia, 2005
- Molecular Mechanisms Activating the Nrf2-Keap1 Pathway of Antioxidant Gene RegulationAntioxidants & Redox Signaling, 2005
- Early Expression and Cellular Localization of Proinflammatory Cytokines Interleukin-1β, Interleukin-6, and Tumor Necrosis Factor-α in Human Traumatic Spinal Cord InjurySpine, 2004